Monogram Orthopaedics Inc. Common Stock (MGRM) — Defensive Interval Ratio

Latest as of June 2025: 6 days

Monogram Orthopaedics Inc. Common Stock (MGRM) has a Defensive Interval Ratio of 6 days as of June 2025. Defensive assets of $97.00K (cash $-, short-term investments $-, receivables $97.00K) cover 6 days of daily cash needs of $17.06K/day. See Monogram Orthopaedics Inc. Common Stock (MGRM) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

6 days
Days of operational coverage

Defensive Assets

$97.00K
Cash + ST Investments + Receivables

Daily Cash Need

$17.06K
Current Liabilities ÷ 365

Current Liabilities

$6.23 Million
USD

Monogram Orthopaedics Inc. Common Stock Defensive Interval Ratio (2021–2024)

This chart shows how Monogram Orthopaedics Inc. Common Stock's Defensive Interval Ratio has evolved across 4 annual periods from 2021 to 2024. As of June 2025, the ratio stands at 6 days, meaning defensive assets of $97.00K can fund 6 days of operations without new revenue. See how leveraged is Monogram Orthopaedics Inc. Common Stock's balance sheet to measure how much of total assets are equity-financed.

Annual Defensive Interval Ratio for Monogram Orthopaedics Inc. Common Stock (2021–2024)

The table below presents the year-by-year Defensive Interval Ratio for Monogram Orthopaedics Inc. Common Stock from 2021 to 2024, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Monogram Orthopaedics Inc. Common Stock market capitalisation.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2024 8 days $32.00K $4.22K/day $- $32.00K ▼ -40 days
2023 47 days $365.00K $7.72K/day $- $- ▲ +41 days
2022 6 days $157.60K $24.79K/day $- $- ▼ -24 days
2021 30 days $418.50K $13.96K/day $- $-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)